Colchicine exerts anti-inflammatory effects by blocking the NLRP3 inflammasome, which is responsible for the production of IL-1β and IL-18.[162] These findings highlight the significance of inflammatory biomarkers in the development of CAD and propose their potential as promising tools in both diagnosis and prognosis. This evidence concerns the gene IL18 and coronary artery disorder.